Altimmune, Inc.
ALT· Nasdaq
Released May 13, 2026, before the open
10-Q filed May 13, 2026, 43 days after period end · 0001326190-26-000040
| Metric | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|---|
| Revenue | — | $5.00K | $5.00K | $21.00K |
| Net Income | -$22.56M | -$19.58M | -$24.39M | -$20.07M |
| EPS Diluted |
Altimmune, Inc. · CIK 1326190 · Engraved from SEC EDGAR
| -$0.18 |
| -$0.26 |
| -$0.34 |
| -$0.40 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.